Ignite Creation Date:
2024-05-06 @ 6:18 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05619913
Status:
RECRUITING
Last Update Posted:
2024-02-08
First Post:
2022-10-26
Brief Title:
EPOCH Eribulin and Pembrolizumab in OvarianUterine Carcinosarcoma
Sponsor:
Australia New Zealand Gynaecological Oncology Group
Organization:
Australia New Zealand Gynaecological Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Uterine Carcinosarcoma |
| Ovarian Carcinosarcoma |
Keywords: